ModelEdge
Albireo Pharma, Inc.
0001322505
Filing type
SC TO-T
Filing date
Jan 22, 2023
Updated
Jan 23, 2023 ยท 1:11 AM

Filing

SC TO-TTender Offer Statement by Third Party

Exhibits

EX-99.(A)(1)(A)OFFER TO PURCHASEEX-99.(A)(1)(B)LETTER OF TRANSMITTALEX-99.(A)(1)(C)NOTICE OF GUARANTEED DELIVERYEX-99.(A)(1)(D)LETTER TO BROKERS,DEALERS,COMMERCIAL BANKS, TRUST COMPANIES AND OTHER NOMINEESEX-99.(A)(1)(E)LETTER TO CLIENTS FOR USE BY BROKERS, DEALERS, ETCEX-99.(A)(1)(F)FORM OF SUMMARY ADVERTISEMENTEX-99.(B)(1)REVOLVING FACILITY AGREEMENTEX-99.(D)(2)(A)MUTUAL CONFIDENTIALITY AGREEMENT, BY AND BETWEEN ALBIREO AND IPSEN BIOSCIENCE INEX-99.(D)(2)(B)MUTUAL CONFIDENTIALITY AGREEMENT, BY AND BETWEEN ALBIREO AND GUARANTOREX-99.(D)(3)EX-99.(D)(3)EX-FILING FEESEX-FILING FEESGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphic